Taken together, these human genetic, biomarker, and experimental murine findings are compatible with the concept that IL-6 trans-signaling is relevant to AAA growth, encouraging larger-scale evaluation of this hypothesis. This evidence concerns the gene IL6 and triple-A syndrome.